Effectiveness and safety of low‐dose apatinib in advanced gastric cancer: A real‐world study

Apatinib has been demonstrated to be effective and safe among patients with gastric cancer failing after at least two lines chemotherapy. This study aimed to evaluate its effectiveness and safety of low‐dose apatinib for the treatment of gastric cancer in real‐world practice. We performed a prospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Yingying, Cao, Qisheng, Jiang, Congqiao, Liang, Hui, Ning, Zhongliang, Ji, Chushu, Wang, Jinguo, Zhou, Chaoping, Jiang, Zonghui, Yu, Changjun, Li, Lei, Zhao, Yong, Xu, Yuemei, Xu, Tengyun, Hu, Wenjun, Wang, Daoqin, Cheng, Huaidong, Wang, Guihe, Zhou, Jinhua, Wang, Song, Zhang, Yanshun, Hu, Zhiqiang, Li, Xinzhong, Lu, Donghui, Zhang, Jun, Xie, Hua, Sun, Guoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367613/
https://www.ncbi.nlm.nih.gov/pubmed/32441892
http://dx.doi.org/10.1002/cam4.3105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367613/
https://www.ncbi.nlm.nih.gov/pubmed/32441892
http://dx.doi.org/10.1002/cam4.3105

Ejemplares similares